1-4 of 4
Wenyan Ji
Close
Sort by
Journal Articles

Increased Monocytic Myeloid-Derived Suppressor Cells Are Associated with Inferior Overall Survival in Patients with Newly Diagnosed Acute Myeloid Leukemia

Amanda C. Przespolewski, Joseph R. Hanson, Wenyan Ji, Tara Cronin, Joseph D. Tario Jr, Eunice S Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6023.
https://doi.org/10.1182/blood-2023-190543
Published: 2023
Journal Articles

Retrospective Comparison of the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) 21-Day Schedule Vs. 28-Day Schedule in Patients with Newly Diagnosed Multiple Myeloma

Alina Varabyeva, Jens Hillengass, Wenyan Ji, Han Yu, McKenna Butler, Eugene Przespolewski
Journal: Blood
Blood (2021) 138 (Supplement 1): 1643.
https://doi.org/10.1182/blood-2021-151182
Published: 2021
Journal Articles

ASXL1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN)

Amro Elshoury, Han Yu, Wenyan Ji, James E. Thompson, Elizabeth A. Griffiths, Amanda Przespolewski, Steven Daniel Green, Pamela J. Sung, Sheeba baAqeel, Hassan Awada, Eunice S. Wang, Peter A. Kouides
Journal: Blood
Blood (2021) 138 (Supplement 1): 3637.
https://doi.org/10.1182/blood-2021-146384
Published: 2021
Journal Articles

Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Amanda Przespolewski, DO, Craig W. Freyer, PharmD, Wenyan Ji, MA, Tara L. Cronin, BA, Swapna Thota, MD, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Amro Elshoury, MBBChir, Jeffrey Baron, PharmD, Mark Walsh, PharmD, Eunice S. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1361.
https://doi.org/10.1182/blood-2019-130582
Published: 2019